Find policies, billing codes, payers, states, and providers
HCPCS P2033: Thymol Turbidity, Blood
HCPCS Level II code P2033 represents the laboratory measurement “thymol turbidity, blood.” As a specialized laboratory assay with limited contemporary clinical use, the code is relevant for billing and historical reporting of biochemical or research-related blood turbidity testing. Nationally, accurate coding ensures proper claims processing and documentation for laboratory services that may be ordered in niche clinical situations or research settings.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise view of what the code denotes, the expected service setting, and the payer landscape covered. The publication outlines common billing considerations, the clinical context for the test, and where to look for payer-specific coverage guidance. It also summarizes typical site-of-service expectations and the role of this assay in laboratory workflows.
This summary is intended for billing managers, laboratory directors, and clinicians who need a clear reference for HCPCS Level II code P2033, including how the code fits into laboratory service lines and the national payer environment. Data not available in the input is noted where applicable in detailed sections.
Customize your policy alerts
Sign up for hcpcs P2033 policy alerts
Get alerted when payer policies referencing P2033 are released or updated.
Monitor payer policy activity
Billing Code Overview
HCPCS Level II code P2033 describes thymol turbidity, blood. This service is a laboratory test that measures the turbidity of blood in the presence of thymol reagent, used historically as a nonspecific indicator in certain clinical and research contexts.
-
Service type: Laboratory test
-
Typical site of service: Clinical laboratory or hospital laboratory